Literature DB >> 22573740

Silencing of endogenous envelope genes in human choriocarcinoma cells shows that envPb1 is involved in heterotypic cell fusions.

Lars Aagaard1,2, Bolette Bjerregaard3,2, Anders L Kjeldbjerg4, Finn Skou Pedersen4, Lars-Inge Larsson3, John J Rossi2.   

Abstract

Syncytin-1 and envPb1 are two conserved envelope genes in the human genome encoded by single loci from the HERV-W and -Pb families, respectively. To characterize the role of these envelope proteins in cell-cell fusion, we have developed lentiviral vectors that express short hairpin RNAs for stable knockdown of syncytin-1 and envPb1. Analysis of heterotypic fusion activity between trophoblast-derived choriocarcinoma BeWo cells, in which syncytin-1 and envPb1 are specifically silenced, and endothelial cells demonstrated that both syncytin-1 and envPb1 are important to fusion. The ability to fuse cells makes syncytin-1 and envPb1 attractive candidate molecules in therapy against cancer. Our available vectors may help eventually to decipher roles for these genes in human health and/or disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22573740      PMCID: PMC3541762          DOI: 10.1099/vir.0.041764-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Syncytin is involved in breast cancer-endothelial cell fusions.

Authors:  B Bjerregaard; S Holck; I J Christensen; L-I Larsson
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

2.  Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta.

Authors:  Reiner Strick; Sven Ackermann; Manuela Langbein; Justine Swiatek; Steffen W Schubert; Said Hashemolhosseini; Thomas Koscheck; Peter A Fasching; Ralf L Schild; Matthias W Beckmann; Pamela L Strissel
Journal:  J Mol Med (Berl)       Date:  2006-10-26       Impact factor: 4.599

3.  Involvement of human endogenous retroviral syncytin-1 in human osteoclast fusion.

Authors:  Kent Søe; Thomas L Andersen; Anne-Sofie Hobolt-Pedersen; Bolette Bjerregaard; Lars-Inge Larsson; Jean-Marie Delaissé
Journal:  Bone       Date:  2010-11-24       Impact factor: 4.398

4.  Expression of the fusogenic HERV-FRD Env glycoprotein (syncytin 2) in human placenta is restricted to villous cytotrophoblastic cells.

Authors:  A Malassiné; S Blaise; K Handschuh; H Lalucque; A Dupressoir; D Evain-Brion; T Heidmann
Journal:  Placenta       Date:  2006-05-22       Impact factor: 3.481

5.  Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis.

Authors:  S Mi; X Lee; X Li; G M Veldman; H Finnerty; L Racie; E LaVallie; X Y Tang; P Edouard; S Howes; J C Keith; J M McCoy
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

6.  A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2.

Authors:  Cécile Esnault; Stéphane Priet; David Ribet; Cécile Vernochet; Thomas Bruls; Christian Lavialle; Jean Weissenbach; Thierry Heidmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

7.  Syncytin immunoreactivity in colorectal cancer: potential prognostic impact.

Authors:  Julie Mou Larsen; Ib Jarle Christensen; Hans Jørgen Nielsen; Ulla Hansen; Bolette Bjerregaard; Jan Fredrik Talts; Lars-Inge Larsson
Journal:  Cancer Lett       Date:  2009-03-26       Impact factor: 8.679

8.  Origins and functional impact of copy number variation in the human genome.

Authors:  Donald F Conrad; Dalila Pinto; Richard Redon; Lars Feuk; Omer Gokcumen; Yujun Zhang; Jan Aerts; T Daniel Andrews; Chris Barnes; Peter Campbell; Tomas Fitzgerald; Min Hu; Chun Hwa Ihm; Kati Kristiansson; Daniel G Macarthur; Jeffrey R Macdonald; Ifejinelo Onyiah; Andy Wing Chun Pang; Sam Robson; Kathy Stirrups; Armand Valsesia; Klaudia Walter; John Wei; Chris Tyler-Smith; Nigel P Carter; Charles Lee; Stephen W Scherer; Matthew E Hurles
Journal:  Nature       Date:  2009-10-07       Impact factor: 49.962

9.  Identification of endogenous retroviral reading frames in the human genome.

Authors:  Palle Villesen; Lars Aagaard; Carsten Wiuf; Finn Skou Pedersen
Journal:  Retrovirology       Date:  2004-10-11       Impact factor: 4.602

10.  Human endogenous retrovirus-FRD envelope protein (syncytin 2) expression in normal and trisomy 21-affected placenta.

Authors:  André Malassiné; Jean-Louis Frendo; Sandra Blaise; Karen Handschuh; Pascale Gerbaud; Vassilis Tsatsaris; Thierry Heidmann; Danièle Evain-Brion
Journal:  Retrovirology       Date:  2008-01-23       Impact factor: 4.602

View more
  4 in total

Review 1.  Human endogenous retrovirus regulates the initiation and progression of cancers (Review).

Authors:  Srishti Sahu; Bharat Singh; Ambak Kumar Rai
Journal:  Mol Clin Oncol       Date:  2022-08-03

2.  Efficient Knockdown and Lack of Passenger Strand Activity by Dicer-Independent shRNAs Expressed from Pol II-Driven MicroRNA Scaffolds.

Authors:  Erik Kaadt; Sidsel Alsing; Claudia R Cecchi; Christian Kroun Damgaard; Thomas J Corydon; Lars Aagaard
Journal:  Mol Ther Nucleic Acids       Date:  2018-12-01

Review 3.  Human endogenous retroviruses in cancer: Expression, regulation and function.

Authors:  Yuan Gao; Xiao-Fang Yu; Ting Chen
Journal:  Oncol Lett       Date:  2020-12-17       Impact factor: 2.967

4.  VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy.

Authors:  Sidsel Alsing; Thomas Koed Doktor; Anne Louise Askou; Emilie Grarup Jensen; Ulvi Ahmadov; Lasse Sommer Kristensen; Brage Storstein Andresen; Lars Aagaard; Thomas J Corydon
Journal:  Mol Ther Nucleic Acids       Date:  2022-02-28       Impact factor: 8.886

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.